Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selegiline | 3 | 2018 | 3 | 0.260 |
Why?
|
| Antigens, Nuclear | 3 | 2012 | 20 | 0.250 |
Why?
|
| Antigens, Neoplasm | 2 | 2025 | 136 | 0.230 |
Why?
|
| Neoplasm Proteins | 2 | 2025 | 289 | 0.220 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2025 | 186 | 0.210 |
Why?
|
| Epitopes | 1 | 2025 | 295 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 511 | 0.190 |
Why?
|
| Melanoma | 1 | 2025 | 334 | 0.180 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 230 | 0.180 |
Why?
|
| Silicon | 1 | 2020 | 17 | 0.160 |
Why?
|
| Quantum Dots | 1 | 2020 | 31 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 185 | 0.160 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1217 | 0.150 |
Why?
|
| Radiation Tolerance | 2 | 2010 | 56 | 0.150 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2018 | 1 | 0.150 |
Why?
|
| Antibodies, Antinuclear | 1 | 2018 | 39 | 0.140 |
Why?
|
| Calcifediol | 1 | 2018 | 3 | 0.140 |
Why?
|
| Steroids | 1 | 2018 | 58 | 0.140 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 22 | 0.140 |
Why?
|
| Dopamine | 1 | 2018 | 108 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 90 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 130 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2018 | 185 | 0.130 |
Why?
|
| Cell Hypoxia | 4 | 2012 | 43 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 148 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 153 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 172 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2018 | 247 | 0.130 |
Why?
|
| Hippocampus | 1 | 2018 | 280 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2018 | 288 | 0.120 |
Why?
|
| DNA Repair | 3 | 2012 | 261 | 0.110 |
Why?
|
| DNA Damage | 3 | 2012 | 300 | 0.110 |
Why?
|
| DNA | 1 | 2018 | 855 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2010 | 12 | 0.100 |
Why?
|
| Indans | 2 | 2018 | 16 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 79 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 213 | 0.090 |
Why?
|
| Defective Viruses | 1 | 2010 | 4 | 0.080 |
Why?
|
| Oxygen | 1 | 2012 | 325 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2010 | 131 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 281 | 0.060 |
Why?
|
| HT29 Cells | 3 | 2012 | 31 | 0.060 |
Why?
|
| Ku Autoantigen | 3 | 2012 | 7 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2008 | 420 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 41 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2005 | 53 | 0.060 |
Why?
|
| Piperidines | 1 | 2005 | 74 | 0.060 |
Why?
|
| Testis | 1 | 2025 | 162 | 0.050 |
Why?
|
| Cell Survival | 3 | 2012 | 601 | 0.050 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 2018 | 10 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2025 | 293 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2025 | 270 | 0.050 |
Why?
|
| Motor Activity | 1 | 2005 | 346 | 0.050 |
Why?
|
| Male | 6 | 2025 | 31073 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 882 | 0.040 |
Why?
|
| Boron | 1 | 2020 | 2 | 0.040 |
Why?
|
| Phosphorus | 1 | 2020 | 16 | 0.040 |
Why?
|
| Luminescence | 1 | 2020 | 19 | 0.040 |
Why?
|
| Rats | 3 | 2010 | 2015 | 0.040 |
Why?
|
| Time Factors | 3 | 2018 | 3789 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 192 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 284 | 0.040 |
Why?
|
| Light | 1 | 2020 | 206 | 0.040 |
Why?
|
| Monoamine Oxidase | 1 | 2018 | 8 | 0.040 |
Why?
|
| Temperature | 1 | 2020 | 316 | 0.040 |
Why?
|
| Corticosterone | 1 | 2018 | 24 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 279 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 427 | 0.040 |
Why?
|
| Radiation Dosage | 2 | 2010 | 140 | 0.040 |
Why?
|
| Linear Models | 2 | 2010 | 409 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 187 | 0.030 |
Why?
|
| Neoplasms | 1 | 2008 | 1415 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 141 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 126 | 0.030 |
Why?
|
| Animals | 6 | 2018 | 21529 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 460 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 152 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 998 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1114 | 0.030 |
Why?
|
| Humans | 6 | 2025 | 65528 | 0.030 |
Why?
|
| Mice | 3 | 2018 | 11215 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2012 | 379 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 17418 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 26 | 0.020 |
Why?
|
| Female | 3 | 2018 | 34125 | 0.020 |
Why?
|
| Arabinofuranosyluracil | 1 | 2008 | 1 | 0.020 |
Why?
|
| Misonidazole | 1 | 2008 | 1 | 0.020 |
Why?
|
| Etanidazole | 1 | 2008 | 1 | 0.020 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2008 | 4 | 0.020 |
Why?
|
| Nitroimidazoles | 1 | 2008 | 4 | 0.020 |
Why?
|
| Carbonic Anhydrases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Autoradiography | 1 | 2008 | 53 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2008 | 18 | 0.020 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2008 | 12 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 172 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 707 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 53 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5442 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4836 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 291 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 294 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 243 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2008 | 50 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2008 | 83 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1050 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 6383 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 227 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 377 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 1108 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 906 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6882 | 0.020 |
Why?
|
| Fenclonine | 1 | 2005 | 1 | 0.010 |
Why?
|
| Aziridines | 1 | 2005 | 3 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1611 | 0.010 |
Why?
|
| Escape Reaction | 1 | 2005 | 8 | 0.010 |
Why?
|
| Choline | 1 | 2005 | 23 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 56 | 0.010 |
Why?
|
| Antiparkinson Agents | 1 | 2005 | 10 | 0.010 |
Why?
|
| Maze Learning | 1 | 2005 | 56 | 0.010 |
Why?
|
| Nortriptyline | 1 | 2005 | 3 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2005 | 146 | 0.010 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 50 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 864 | 0.010 |
Why?
|
| Swimming | 1 | 2005 | 29 | 0.010 |
Why?
|
| Reaction Time | 1 | 2005 | 128 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 192 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 612 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 2071 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 238 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2010 | 828 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 1471 | 0.010 |
Why?
|